Status:
COMPLETED
Tranexamic Acid in HIp Fracture Surgery (THIF Study)
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Hip Fracture
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess the efficacy of tranexamic acid in hip fracture surgery on the reduction of allogeneic red blood cell transfusion.
Detailed Description
Studies in hip and knee arthroplasty (scheduled surgery) have shown that tranexamic acid decreases allogeneic red blood cell transfusion. In hip fracture surgery, an emergent procedure, transfusion is...
Eligibility Criteria
Inclusion
- Patient requiring surgery for an isolated hip fracture of less than 48 hours
Exclusion
- Contraindication to tranexamic acid
- Contraindication to fondaparinux
- Contraindication to general anesthesia associated with a femoral nerve block
- pregnancy
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT00327106
Start Date
April 1 2005
End Date
February 1 2007
Last Update
June 11 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Saint-Etienne
Saint-Étienne-de-Montluc, Pays de la Loire Region, France, 42055